3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
4
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lung Neoplasms
1
Hot Flashes
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Breast Neoplasms
1
Interventions
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
vinflunine
1
pembrolizumab
1
enfortumab vedotin
1
cabozantinib
1
avelumab
1
Watchful Waiting
1
Vitamin B 12
1
Platinum
1
Pemetrexed
1
Paclitaxel
1
Observation
1
Morphine
1
Immunoglobulin G
1
Gemcitabine
1
Folic Acid
1
Docetaxel
1
Disulfides
1
Dexamethasone
1
Cystoscopy
1
Cisplatin
1
Calcium Dobesilate
1
Bupivacaine
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Ureteral Neoplasms
×
Folic Acid
×
Clear all
NCT03193788
2017-06-21
PREMIER
Asan Medical Center
Phase 3
Unknown
74 enrolled